Cold Chain Smart Solutions Conference

Fleming Europe19 - 21 January 2011, Barcelona, Spain
The Cold Chain Smart Solutions Conference is the perfect place to get up to speed with the latest regulations, technology and processes that are necessary to operate a cost-effective and compliant temperature controlled supply chain.

Due to greater temperature ranges and novel biotech drugs coming onto market the number of cold chain shipments by air, road and sea continue increasing. Temperature controlled and pharmaceutical shipping are widely expected to lead the recovery in terms of growth rates. Therefore the most immediate investment priorities of pharmaceutical, shipper, wholesaler companies and CMOs should include cold chain capabilities.

By attending you will have the chance to listen to conference presentations, panel discussions, specialist discussion forums, tailor-made streams about the burning topics of the industry - such as the most updated regulatory roadmap, quality systems and agreements, RF-enabled product visibility, electronic temperature monitoring, satellite tracking, "Last mile" issues, new market focus on Asia, shipping by ocean, cold chain packaging & shipping smart solutions: PCM, going green, active ULDs, battery-assisted passive RFID, etc.

In the frame of a highly interactive Post-Conference Workshop you will gain an insight into the newest real-life strategies how to mitigate the risks and optimize the cold chain costs efficaciously.

Furthermore, you will have excellent opportunities to network with temperature controlled supply chain stakeholders from:

  • Pharmaceutical, Biotech and Medical Device Manufacturers
  • Transportation Providers
  • Government Healthcare Agencies and Shippers
  • Freight forwarders
  • Packaging Partners
  • Wholesalers

As a comprehensive and one-of-its kind event, the Cold Chain Smart Solutions Conference will address the most urgent challenges of the global marketplace for the storage and distribution of temperature sensitive pharmaceuticals, biopharmaceuticals, vaccines, etc.

For further information and brochure request, please visit:
http://www.flemingeurope.com/life-science-conferences/europe/cold-chain-smart-solutions

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Researchers develop a new method for turning skin …

Our bodies consist of many different kinds of cells, each with their own role. The Japanese scientist Shinya Yamanaka had made earlier the discovery, earning the Nobel Pr...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

How targeting metabolism can defeat cancer stem ce…

Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment. In a breakthroug...

New small molecules pave the way for treating auto…

The innate immune system is the first line of defense, with cells that quickly identify "foreign" motifs from viruses and bacteria and mount up a counterattack to elimina...